| Pharmacology of Ocular Therapeutics T Velpandian Springer International Publishing, Switzerland., 2016 | 27 | 2016 |
| Ulcer protective activity of Jatropha gossypiifolia Linn. in wistar rats AR Vijayakumar, EP Daniel, R Ilavarasan, S Venkataraman, ... Pharmacognosy research 8 (Suppl 1), S61, 2016 | 20 | 2016 |
| Evaluation of calcium dobesilate for its anti-cataract potential in experimental animal models. T Velpandian, J Nirmal, P Gupta, AR Vijayakumar, S Ghose Methods and findings in experimental and clinical pharmacology 32 (3), 171, 2010 | 20 | 2010 |
| ISO 13485 Medical Devices-Quality management systems-Requirments for regulatory purposes. B Karthika, AR Vijayakumar Medical device Guidelines and Regulations Handbook 1, 19-30., 2022 | 8 | 2022 |
| Evaluation of the protective effect of NMDA/non-NMDA receptor antagonists against ethambutol induced retinal toxicity using ERG in wistar rats AR Vijayakumar, H Anuradha, NR Biswas, V Menon, R Saxena, N Halder, ... Indian J Physiol Pharmacol 60 (3), 268-281, 2016 | 7 | 2016 |
| Utility of the trough plasma imatinib level monitoring at two time points in patients with the chronic myeloid leukemia-chronic phase SK Sharma, S Kumar, AR Vijayakumar, T Seth, P Mishra, M Mahapatra, ... Journal of Cancer Research and Therapeutics 10 (2), 305-308, 2014 | 7 | 2014 |
| BIN1 in the Pursuit of Ousting the Alzheimer’s Reign: Impact on Amyloid and Tau Neuropathology I Kaur, T Behl, G Sundararajan, P Panneerselvam, AR Vijayakumar, ... Neurotoxicity Research 41 (6), 698-707, 2023 | 4 | 2023 |
| Formulation and Evaluation of Ranolazine Fast Dissolving Tablets Using Various Superdisintegrants V Murugesan, S Balaraman, M Krishnamoorthy, AR Vijayakumar, ... J Young Pharm 57 (1), 124-131, 2022 | 3 | 2022 |
| Larvicidal Activity and Molecular Docking Studies of Vitexicarpin from Vitex negundo Linn K Sandhya, M Sivakumar, AR Vijayakumar Journal of Young Pharmacists 13 (3), 223, 2021 | 3 | 2021 |
| Essential of Ocular Pharmacology AP Agarwal R Ocular adverse effects of systemically administered drugs; Vijayakumar, AR …, 2011 | 3* | 2011 |
| Fabrication and Validation of Gyro-Dot-Optomotor Response Device using Gold Fish to Study Drugs Affecting Visual Perception AR Vijayakumar, NR Biswas, V Menon, R Saxena, W Ahmed, N Halder, ... Ind J Physiol Pharmacol 60, 182-192, 2016 | 2 | 2016 |
| Design and Synthesis of Pyrazole-Substituted 9-Anilinoacridine Derivatives and Evaluation against Breast Cancer TBE Dhinesh Kumar Murugesan, Kalirajan Rajagopal, A R Vijayakumar, G ... Journal of Biological Regulators and Homeostatic Agents. 38 (4), 2845-2859, 2024 | 1 | 2024 |
| Is Daclatasvir a suitable substitute for Amphotericin B in the treatment of Mucormycosis when Amphotericin B is scarce? P Thangaraju, SST Yella, AR Vijayakumar, S Muthusamy, LHMT Ansari, ... Current Drug Research Reviews, 2023 | 1 | 2023 |
| Molecular docking analysis of Adhatoda Vasica withThromboxane A2 receptor (TXA2R)(6IIU) and Antiviral molecules for possible dengue complications P Thangaraju, N Gopinathan, V Ar, MP Gurunthalingam, SS Ty, ... Infectious disorders drug targets, 2022 | 1* | 2022 |
| Effect of carbon tetrachloride-induced hepatic injury on Luffa acutangula (var.) amara E Prabu Daniel, AR Vijayakumar, W Clement Atlee, R Ilavarasan, ... Pharmacognosy Research 12 (3), 278-284, 2020 | 1 | 2020 |
| A Nonsystematic Review on Risankizumab: a Novel Drug Recently approved for Moderate to Severe Psoriasis V Shoban Babu, T Pugazhenthan, V Sajitha, AR Vijayakumar, T Eswaran SN Compr Clin Med, 1-9, 2020 | 1* | 2020 |
| A Prospective Study on Drug Audit, Prescribing Patterns Assessment, and Clinical Outcomes Evaluation in a Tertiary Care Hospital, Tamil Nadu, India. S Vijayakumar, S Parimalakrishnan, DP Anand, M Karthika, ... Journal of Young Pharm 15 (4), 734-742, 2023 | | 2023 |
| A Perspective into “TEL”-Tenofovir, Emtricitabine and Lamivudine Antileprotic Activities by Drug Repurposing and Exploring the Possibility of Combination Chemotherapy with Drug … P Thangaraju, SST Yella, AR Vijayakumar, I Navabshan, TALH Mohamed Recent Advances in Anti-Infective Drug Discovery Formerly Recent Patents on …, 2023 | | 2023 |
| Double beamUV Spectrophotometer for determining drug content N Deepa, AR Vijayakumar, M Sivakumar, GP Senthilkumar, PK Anamika IN Patent App. 386566-001., 2023 | | 2023 |
| ROLE OF BIOMARKERS IN DRUG DEVELOPMENT AND CLINICAL TRAILS D Ronald, AR Vijayakumar REVIEW ON PHARMACEUCTICAL TECHNOLOGY, 1-8, 2023 | | 2023 |
Dr.Velpandian ThirumurthyProfessor, Ocular Pharmacology & Pharmacy Div, Dr.RPCentre, AIIMS, New Delhi在 aiims.ac.in 的电子邮件经过验证
